Stock Picks


  • Second half playbook: Pros hunt for value Monday, 30 Jun 2014 | 4:16 PM ET
    Trader on the floor of the New York Stock Exchange.

    Investors are placing bets on how the second half of 2014 will unfold. Here are their picks.

  • Bye bye Bordeaux: The new bull market for wine Monday, 30 Jun 2014 | 3:50 PM ET
    Three bottles of 2005 Romanée-Conti from Burgundy sold on June 26 for $40,137.50.

    Bordeaux wine prices have pulled fine wine indexes sharply lower. But a look at wines across other regions reveals a more bullish story.

  • Big blow to big labor  Monday, 30 Jun 2014 | 2:11 PM ET

    The U.S. Supreme Court ruled home care workers cannot be forced to pay union fees. Ross Eisenbrey, Economic Policy Institute, and E.J. McMahon, Empire Center for Public Policy, discuss what this means for unions.

  • Second half picks: SUSQ, MTW & VLO  Monday, 30 Jun 2014 | 2:00 PM ET

    As the market transitions into the second half of the year, what can investors expect? Michael Crofton, Philadelphia Trust Company CEO, and Peter Sorrentino, Huntington Asset Advisors, give their best stock picks for your portfolio.

  • Second half health care outlook  Monday, 30 Jun 2014 | 1:50 PM ET

    Large cap health care continues to outperform the broader market, but they are slowing. CNBC's Bertha Coombs reports the outlook for the rest of the year.

  • Small cap pro sees bumpy road ahead  Monday, 30 Jun 2014 | 12:40 PM ET

    Discussing the performance of small cap stocks, and what more M&A deals mean for these stocks, with Steven DeSanctis, BofA Merrill Lynch head of small cap strategy.

  • 'Scar' still burns for retail investors: Cashin Monday, 30 Jun 2014 | 11:50 AM ET
    Art Cashin

    Stocks may be at highs, but retail investors are still spooked about getting back into the market, says veteran trader Art Cashin.

  • Cramer's Stop Trading: 'Amazed' with GW Pharma  Monday, 30 Jun 2014 | 9:51 AM ET

    CNBC's Jim Cramer explains why he continues to watch the potential market size for GW Pharmaceuticals' orphan drug Epidiolex.

  • Cramer's Mad Dash: Be long Yahoo  Monday, 30 Jun 2014 | 9:28 AM ET

    Jim Cramer explains what to watch ahead of the open, including how Alibaba will impact Yahoo.

  • Jim Cramer on Mad Money.

    You need to generate enough money to support yourself for the rest of your life by the time you plan on retiring, says Mad Money host Jim Cramer.

  • Diversification comes before everything when you are investing in your discretionary portfolio or 401(k), says Mad Money host Jim Cramer.

  • Cramer’s Playbook: 3 tactics to maximize gains Friday, 27 Jun 2014 | 6:02 PM ET
    Jim Cramer on Mad Money.

    Feel like the pros know something that you don’t? Cramer understands.

  • Most important elements of capital preservation  Friday, 27 Jun 2014 | 6:00 PM ET

    Mad Money host Jim Cramer says paying off credit card debt, and getting health and disability insurance are the most important elements of capital preservation.

  • The Final Call: BAC'S tough outlook  Friday, 27 Jun 2014 | 5:58 PM ET

    CNBC's Melissa Lee and the Options Action traders discuss the stocks they'll be watching next week.

  • Why GE is missing the rally  Friday, 27 Jun 2014 | 5:53 PM ET

    Losing capital on GE, with CNBC's Melissa Lee and the Options Action traders.

  • Will Alibaba IPO crush Yahoo?  Friday, 27 Jun 2014 | 5:43 PM ET

    What's next for Yahoo post Alibaba IPO, with CNBC's Melissa Lee and the Options Action traders.

  • Traders bet on a Vegas recovery  Friday, 27 Jun 2014 | 5:35 PM ET

    Vegas gaming revenue jumps, with CNBC's Melissa Lee and the Options Action traders.

  • This could be key for the rally  Friday, 27 Jun 2014 | 5:30 PM ET

    What stocks need to keep going, with CNBC's Melissa Lee and the Options Action traders.

  • Bullish bets on IDTI  Friday, 27 Jun 2014 | 5:30 PM ET

    FM trader Jon Najarian looks into unusual activity in Integrated Device Technology.

  • Stock Pops & Drops: DG, ANF, GMCR, DD  Friday, 27 Jun 2014 | 5:23 PM ET

    The Fast Money traders take a look at today's biggest market movers.